Concordance of Pharmacist Assessment of Medication Nonadherence With a Self-Report Medication Adherence Scale

Michael S Kelly1, Leticia R Moczygemba2, Sharon S Gatewood3

  • 1School of Pharmacy, Virginia Commonwealth University, Richmond, VA, USA.

Abstract

Insights

The Modified Morisky Scale (MMS) showed poor concordance with pharmacist assessments of medication adherence in behavioral health patients. Combining self-report tools with pharmacist evaluations may offer better adherence insights.

Area of Science:

  • Pharmacology
  • Behavioral Health
  • Clinical Pharmacy

Background:

  • Medication adherence is crucial for treatment success, especially in behavioral health.
  • Accurate assessment of adherence is challenging.
  • The Modified Morisky Scale (MMS) is a self-report tool used to measure adherence.

Purpose of the Study:

  • To evaluate the concordance between the Modified Morisky Scale (MMS) and pharmacist assessments of medication adherence.
  • To compare the 6-item MMS and the original 4-item Morisky Scale against pharmacist evaluations.

Main Methods:

  • Retrospective analysis of electronic medical records (EMRs) from a homeless behavioral health clinic.
  • Included patients aged 18+ who underwent pharmacist medication reviews.
  • Used McNemar test to assess agreement between MMS (6-item and 4-item) and pharmacist adherence assessments.

Main Results:

  • Nonadherence rates were higher with the MMS (61.7% for 6-item, 49.7% for 4-item) compared to pharmacist assessment (23.8%).
  • Significant differences (P < .0001) were found between MMS scores and pharmacist assessments.
  • The study included 288 patients and 449 medication reviews.

Conclusions:

  • The Modified Morisky Scale (MMS) demonstrated low concordance with pharmacist adherence assessments.
  • Pharmacist evaluations identified lower rates of nonadherence than the MMS.
  • A combination of self-report and clinical assessment may be optimal for evaluating medication adherence.

Related Concept Videos

Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
387
Drug Dosage Regimen: Overview01:15

Drug Dosage Regimen: Overview

A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
4.1K
Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
436
Dosage Regimens: Designs and Approaches01:28

Dosage Regimens: Designs and Approaches

Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
589
Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
2.0K
Assessment of the Gastrointestinal System I: Subjective Data01:17

Assessment of the Gastrointestinal System I: Subjective Data

Assessing the gastrointestinal (GI) system is a complex process that begins with collecting subjective data. This data, collected through patient interviews, provides crucial insights into the patient's health history, perception patterns, and lifestyle habits, all contributing significantly to GI health.
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems...
842